BioPharma segment tarnishes Cambrex 2Q
Cambrex has recorded a gain in the second quarter of this year, with growth in its Bioproducts and Human Health segments. The performances overshadow the company's troublesome BioPharma division, indicative of a market for outsourced manufacturing of...